Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 121 - 130 of 222 for bay. (0.06 seconds)

Both Have Thin Pipelines. More details...
CBT 200 Gets Positive For 2006. More details...
After Slow Uptake And A Burst Of Activity, Another...
CBT 200 Climbs 20 Points. More details...
CBT 200 Drops 7 Points. More details...
CBT 200 Rises 35 Points. More details...
Companies Seek The Right Mix. More details...
CBT 200 Flat Ahead of Fed Announcement Tomorrow. More...
Indirect Costs Very High For Certain Cancers . More...
Thoughts About the 25th Annual Meeting. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital